NCT02942368View on ClinicalTrials.gov

Adaptive tDCS for Treatment-Resistant MDD

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 14, 2017

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Depressive Disorder, Treatment-Resistant
Interventions
DEVICE

tDCS

Transcranial direct current stimulation with placement of the anode over the F3 region of the scalp and the cathode over the right supraorbital region.

Trial Locations (1)

63110

Washington University in Saint Louis, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02942368 - Adaptive tDCS for Treatment-Resistant MDD | Biotech Hunter | Biotech Hunter